Meemanage, Madusha
Spender, Lindsay C.
Collinson, Diane
Iannetta, Joanna
Challapalli, Pranavi
Turbitt, Julie
Clark, Caroline
Baxter, Mark
Murray, Graeme
Walsh, Shaun
Miedzybrodzka, Zofia
Petty, Russell D. http://orcid.org/0000-0003-2055-4572
Funding for this research was provided by:
Chief Scientist Office (TCS/19/18)
Ninewells Cancer Campaign
University of Dundee
Article History
Received: 11 June 2020
Accepted: 19 October 2020
First Online: 9 November 2020
Compliance with ethical standards
:
: RDP has undertaken speaking, consulting and advisory roles for Eli Lilly, BMS, Pfizer, Sanofi, Servier; and received research funding (not related to the work in this manuscript) from Astra Zeneca, Roche, MSD, Merck serrano, Eli Lilly, Five Prime Therapeutics, Clovis, Boston Biomedical, and Janssen. LCS, MM, JI, PC, DC, JT, CC, GM, SW, ZM and MB declare no conflict of interest.
: Ethical approval for use of human tissue in this study was obtained from the Scientific Access Committees of the Grampian Tissue Biorepository and the Tayside Biorepository. The Biorepositories have delegated research ethics authority from The North of Scotland research ethics committee (Grampian) and the East of Scotland research ethics committee (Tayside) to approve research projects involving human tissue and data. All tissue and data were anonymised. The study was performed in accordance with the Declaration of Helsinki.
: Project specific written consent was not required for the retrospective use of archival tissue.
: All data reported in this manuscript are included in the figures and tables.
: Not applicable.
: Not applicable.